Hypofractionated Acute Toxicity versus conventionally fractionated radiotherapy in patients with Prostate Cancer

被引:0
|
作者
Lohr, Frank [1 ]
Ehmann, Michael [1 ]
机构
[1] Univ Med Mannheim, Klin Strahlentherapie & Radioonkol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
关键词
RANDOMIZED-TRIAL; FAILURE;
D O I
10.1007/s00066-015-0924-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:67 / 69
页数:3
相关论文
共 50 条
  • [1] Comparative evaluation of hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate and high risk prostate cancer
    Soni, Abhishek
    Jadhav, Ganesh K.
    Manocha, Sapna
    Chauhan, Sunil
    Goswami, Brijesh
    Verma, Monica
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (06) : 1001 - 1009
  • [2] Conventionally fractionated versus hypofractionated radiotherapy in elderly glioblastoma patients
    Lee, H. I.
    Kim, J.
    Kim, I. A.
    Lee, J. H.
    Yoon, H. I.
    Wee, C. W.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S539 - S539
  • [3] Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
    Aluwini, Shafak
    Pos, Floris
    Schimmel, Erik
    van Lin, Emile
    Krol, Stijn
    van der Toorn, Peter Paul
    de Jager, Hanja
    Dirkx, Maarten
    Alemayehu, Wendimagegn Ghidey
    Heijmen, Ben
    Incrocci, Luca
    LANCET ONCOLOGY, 2015, 16 (03): : 274 - 283
  • [4] Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer
    McDonald, Andrew M.
    Jacob, Rojymon
    Dobelbower, Michael C.
    Kim, Robert Y.
    Fiveash, John B.
    ACTA ONCOLOGICA, 2013, 52 (06) : 1181 - 1188
  • [5] Hypofractionated or conventionally fractionated radiotherapy for early glottis cancer
    Gutierrez Bayard, L.
    Salas Buzon, M. C.
    De Ingunza Baron, L.
    Villanego Beltran, I.
    Diaz Diaz, V.
    Gonzalez Calvo, E.
    Diaz Gomez, L.
    Jaen Olasolo, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S571 - S571
  • [6] Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
    Aluwini, Shafak
    Pos, Floris
    Schimmel, Erik
    Krol, Stijn
    van der Toorn, Peter Paul
    de Jager, Hanja
    Alemayehu, Wendimagegn Ghidey
    Heemsbergen, Wilma
    Heijmen, Ben
    Incrocci, Luca
    LANCET ONCOLOGY, 2016, 17 (04): : 464 - 474
  • [7] Hypofractionated vs. conventionally fractionated radiotherapy for prostate cancer: A meta-analysis
    Shaikh, M. P.
    Alite, F.
    Wu, M. J.
    Altoos, T.
    Jacobson, G. M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S334 - S334
  • [8] Akuttoxizität nach hypofraktionierter versus konventionell fraktionierter Strahlentherapie bei Patienten mit ProstatakarzinomAcute toxicity after hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer
    Frank Lohr
    Michael Ehmann
    Strahlentherapie und Onkologie, 2016, 192 (1) : 67 - 69
  • [9] Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature
    Francolini, G.
    Detti, B.
    Becherini, C.
    Caini, S.
    Ingrosso, G.
    Di Cataldo, Vanessa
    Stocchi, G.
    Salvestrini, V.
    Lancia, A.
    Scartoni, D.
    Giacomelli, I.
    Sardaro, A.
    Carbonara, R.
    Borghesi, S.
    Aristei, C.
    Livi, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
  • [10] Salvage hypofractionated radiotherapy for prostate cancer: acute toxicity
    Saldi, S.
    Bellavita, R.
    Palumbo, I.
    Mariucci, C.
    Arena, E.
    Lupattelli, M.
    Podlesko, A.
    Russo, S.
    Dottorini, R.
    Bini, V.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S725 - S725